Tweets By:

Bio: Bioech/healthcare investor, on the street of Wall for EVER, bought first biotech-AMGN- in '84. sportsaholic & wine enthusiast. Father to 3 great girls

03:45 PM  06/20/18 reply  |  re-tweet

RT @psk2329: $SGMO (Msgs, Twts) Sangamo initiated w/Buy at BofA/Merrill analyst Qian Wang saying has 1 of most advanced pipelines in clinic using zinc f…

01:26 PM  06/20/18 reply  |  re-tweet

@_B_I_O_T_E_C_H_ What a joke. Both $TSRO (Msgs, Twts) & $CLVS (Msgs, Twts) have been shopped over the last few years with no takers.

08:33 AM  06/20/18 reply  |  re-tweet

$IMMU (Msgs, Twts) lots of triggers on the horizon---should meaningfully outperform near-term https://t.co/TUL7IZJuup

08:25 AM  06/20/18 reply  |  re-tweet

RT @BioStocks: $SGMO (Msgs, Twts) initiated at Buy at BofA/Merrill. PT $24

08:10 AM  06/20/18 reply  |  re-tweet

$SRPT (Msgs, Twts) Leerink ---we expect momentum to continue for the stock--as the update should increase investor optomism for… https://t.co/RRCFKKXFYB

08:11 PM  06/19/18 reply  |  re-tweet

@sharkbiotech @carlquintanilla @CNBC $GE (Msgs, Twts) has been a POS since Jack Welch stopped cooking the books using that nicke… https://t.co/qCLbGu89oy

04:04 PM  06/19/18 reply  |  re-tweet

RT @_B_I_O_T_E_C_H_: MIZUHO Putting $SRPT (Msgs, Twts) Data into Context ... Not Much Has Really Changed for $WVE (Msgs, Twts) in Our View SRPT just (cont) https://t…

01:51 PM  06/19/18 reply  |  re-tweet

$SRPT (Msgs, Twts) JPM---company transitioning to the next emerging large cap --$SRPT (Msgs, Twts) has the shots on goal/profile to get there… https://t.co/FSVXkVWkTh

12:17 PM  06/18/18 reply  |  re-tweet

RT @_B_I_O_T_E_C_H_: $BIIB (Msgs, Twts) better pull the trigger fast here ... $IONS (Msgs, Twts) fun over with new $PTCT (Msgs, Twts) drug $SGMO (Msgs, Twts) gene editing next for CNS ....…

08:13 PM  06/15/18 reply  |  re-tweet

@BigChodu I don’t believe anyone thinks $TSRO (Msgs, Twts) is the best of breed in today’s market

08:12 AM  06/13/18 reply  |  re-tweet

$ZGNX (Msgs, Twts) top line data from Dravet study due any day -- lots of potential for ZX008 to excite investors for this unmet need

06:30 PM  06/12/18 reply  |  re-tweet

$IMMU (Msgs, Twts) chart does look great! Look for bullish news coming out very shortly to take this up nicely. https://t.co/3yNNYTR3Xe

02:17 PM  06/12/18 reply  |  re-tweet

$IMMU (Msgs, Twts) this offering is being done to give the BIG LONG FUNDS---who have avoided this in the past -- an oppy to part… https://t.co/WVn6WaCN99

12:01 AM  06/04/18 reply  |  re-tweet

RT @Biomaven: Very nice quote from Picozzi (who is arguably top doc in pancreatic cancer) on $FGEN (Msgs, Twts)'s pamrevlumab: “These are some of the mo…

10:45 AM  05/21/18 reply  |  re-tweet

@tgtxdough MS says large cap $CELG (Msgs, Twts) $GILD (Msgs, Twts) $REGN (Msgs, Twts) continue to re-rate lower, keeping many generalist growth investors away from the sector

07:49 AM  05/17/18 reply  |  re-tweet

$IMMU (Msgs, Twts) hats off to Eric Schmidt of Cowen for seeing the potential @ $3/sh and stepping up to the plate ! https://t.co/uL4YTqAVc2

07:46 AM  05/17/18 reply  |  re-tweet

$IMMU (Msgs, Twts) new 52 week high off excellent ASCO update !

12:53 PM  05/14/18 reply  |  re-tweet

$IMMU (Msgs, Twts) look for market moving data this Wednesday at ASCO

08:50 AM  05/11/18 reply  |  re-tweet

$AKTX (Msgs, Twts) this bucket shop can't keep a CEO ! One gets booted for lying on trial results & the next clown has to steal… https://t.co/Eh1lxpkZ0S

03:10 PM  05/08/18 reply  |  re-tweet

RT @_B_I_O_T_E_C_H_: Barclays $SGMO (Msgs, Twts) REPORTED CONTINUED PROGRESS IN MULTIPLE CLINICAL PROGRAMS Price Target $30.00 DOWNSIDE case (if tox et…

12:25 PM  05/08/18 reply  |  re-tweet

$ALXN (Msgs, Twts) 1210 has strong data & a better profile. BUYING OPPORTUNITY HERE per Cowen

12:24 PM  05/08/18 reply  |  re-tweet

$ALXN (Msgs, Twts) Cowen continues to see reasonable chance patent is issued & protects the franchise an additional 5 yrs, Impor… https://t.co/8Eb4712w2H

07:32 AM  05/07/18 reply  |  re-tweet

$CELG (Msgs, Twts) Leerink--Small changes in the right direction but bullish tone not backed by performance. Outperform---price… https://t.co/lVog3lB9Tj

07:08 AM  05/07/18 reply  |  re-tweet

$CELG (Msgs, Twts) downgraded by RBC from Top Pick to Outperform--price target goes from $120 to $118

12:37 PM  05/04/18 reply  |  re-tweet

@GantosJ @douglas_ingram My guess a few were also short $PTLA (Msgs, Twts).......ouch

Top Searches Feeds

StockTalk Aggregated Feed (includes All Daily and Weekly Editions) Add to My Yahoo! Add to Google
Top Searches Today - 10 (10 hottest stocks) Add to My Yahoo! Add to Google
Web BuZZ Today - 10 (10 hottest stocks) Add to My Yahoo! Add to Google
Twitter BuZZ Today - 10 (10 hottest stocks) Add to My Yahoo! Add to Google

Web BuZZ

Yesterday

TSLA
CPB

Today

JPM
More >> RSS Feed
140 close
You will be redirected to the Twitter's authorization page to approve the BoardCentral to connect to your Twitter account. After your approval, the tweet you have entered will be posted.
Out